• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Adults with type 2 diabetes face high risk of dying from cancer

Bioengineer by Bioengineer
July 3, 2019
in Cancer
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Cancer has overtaken cardiovascular disease as the most common cause of death in Scottish adults with type 2 diabetes, according to a study published in the Journal of Diabetes Investigation.

Investigators examined the causes of death of people with type 2 diabetes in Ayrshire and Arran, Scotland between 2009 and 2014 and compared them with national mortality rates. The most common cause of death was cancer (27.8%) followed by heart disease (24.1%).

The study’s results confirmed an increased risk of early death in individuals with type 2 diabetes compared with the general population, and they suggested that where cardiovascular risk factors are being treated aggressively, cancer takes on a greater importance in the cause of death.

###

Media Contact
Penny Smith
[email protected]
http://dx.doi.org/10.1111/jdi.13067

Tags: cancerCardiologyDiabetesMedicine/HealthMetabolism/Metabolic DiseasesPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

New Drug Blocking Tumor Blood Supply Shows Promise in Extending Survival for Children with Bone Cancer

October 23, 2025

CGREF1 Boosts Colorectal Cancer Migration, Indicates Poor Prognosis

October 23, 2025

MSK Unveils Cutting-Edge Research at ESMO 2025: Advances in Lung and Pancreatic Cancer Therapies

October 22, 2025

Candida, Immunity, and Cancer: Unraveling Tumor Links

October 22, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1275 shares
    Share 509 Tweet 318
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    307 shares
    Share 123 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    159 shares
    Share 64 Tweet 40
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    132 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tidal Volume and Peak Pressure: Key Predictors in Jet Ventilation

TU Graz Explores Preservation of Endangered Cultural Heritage in the Western Himalayas

SARS-CoV-2 mRNA Vaccines Boost Tumor Immunotherapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.